María del Pilar
Herrera Puente

Profesor/a Asociado/a en CC. de la Salud

Foto de María del Pilar

Foto de Hospital Universitari de Tarragona Joan XXIII

Hospital Universitari de Tarragona Joan XXIII

Tarragona, España

Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Tarragona Joan XXIII (4)

2024

Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552

2023

Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
HemaSphere

2022

Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain
Leukemia and Lymphoma

2021

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group
Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938